{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:57:58Z","timestamp":1790981878824,"version":"4.1.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2010,5,25]],"date-time":"2010-05-25T00:00:00Z","timestamp":1274745600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0000720","type":"journal-article","created":{"date-parts":[[2010,5,25]],"date-time":"2010-05-25T18:38:54Z","timestamp":1274812734000},"page":"e720","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":118,"title":["NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness"],"prefix":"10.1371","volume":"4","author":[{"given":"Oliver","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Priotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Flevaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Chappuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,5,25]]},"reference":[{"key":"ref1","first-page":"71","article-title":"Human African trypanosomiasis (sleeping sickness): Epidemiological update.","volume":"8","year":"2006"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1371\/journal.pmed.0050055","article-title":"Eliminating human African trypanosomiasis: where do we stand and what comes next?","volume":"5","author":"PP Simarro","year":"2008","journal-title":"PLoS Med"},{"key":"ref3","year":"2010"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMra064142","article-title":"Control of neglected tropical diseases.","volume":"357","author":"PJ Hotez","year":"2007","journal-title":"N Engl J Med"},{"key":"ref5","year":"2009"},{"key":"ref6","year":"2009"},{"key":"ref7","year":"2009"},{"key":"ref8","first-page":"475","article-title":"Clinical trials with \u201cnifurtimox\u201d in African trypanosomiasis.","volume":"57","author":"PG Janssens","year":"1977","journal-title":"Ann Soc Belg Med Trop"},{"key":"ref9","first-page":"37","article-title":"[Clinical trial of nifurtimox in human African trypanosomiasis.]","volume":"64","author":"F Moens","year":"1984"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0035-9203(92)90298-Q","article-title":"High-dose nifurtimox for arseno-resistant <italic>Trypanosoma brucei gambiense<\/italic> sleeping sickness: an open trial in central Zaire.","volume":"86","author":"J Pepin","year":"1992","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pctr.0010039","article-title":"Three drug combinations for late-stage <italic>Trypanosoma brucei gambiense<\/italic> sleeping sickness: a randomized clinical trial in Uganda.","volume":"1","author":"G Priotto","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1371\/journal.pntd.0000064","article-title":"Nifurtimox plus eflornithine for late-stage sleeping sickness in Uganda: a case series.","volume":"1","author":"F Checchi","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","article-title":"Nifurtimox-eflornithine combination therapy for second-stage <italic>Trypanosoma brucei gambiense<\/italic> sleeping sickness: a randomized clinical trial in Congo.","volume":"45","author":"G Priotto","year":"2007","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African <italic>Trypanosoma brucei gambiense<\/italic> trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial.","volume":"374","author":"G Priotto","year":"2009","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(09)61163-6","article-title":"NECT trial: more than a small victory over sleeping sickness.","volume":"374","author":"J Opigo","year":"2009","journal-title":"Lancet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-3156.2007.01999.x","article-title":"Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola.","volume":"13","author":"J Robays","year":"2008","journal-title":"Trop Med Int Health"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.","volume":"152","author":"MP Barrett","year":"2007","journal-title":"Br J Pharmacol"},{"key":"ref18","year":"2009"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S1473-3099(09)70313-5","article-title":"New treatment for sleeping sickness still not implemented.","volume":"9","author":"K Morris","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis.","volume":"375","author":"R Brun","year":"2009","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/0035-9203(95)90673-8","article-title":"Risk factors for encephalopathy and mortality during melarsoprol treatment of <italic>Trypanosoma brucei gambiense<\/italic> sleeping sickness.","volume":"89","author":"J Pepin","year":"1995","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref22","first-page":"1","article-title":"Control and surveillance of African trypanosomiasis: Report of a WHO expert committee. WHO Technical Report Series 881. Geneva: WHO.","volume":"881","year":"1998","journal-title":"World Health Organ Tech Rep Ser"},{"key":"ref23","author":"J Seixas","year":"2004"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1086\/429929","article-title":"Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: confirmation from a multinational study (IMPAMEL II).","volume":"191","author":"C Schmid","year":"2005","journal-title":"J Infect Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1046\/j.1365-3156.2001.00725.x","article-title":"Pharmacokinetic investigations in patients from northern Angola refractory to melarsoprol treatment.","volume":"6","author":"C Burri","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0035-9203(99)90151-7","article-title":"Risk factors for treatment failure after melarsoprol for <italic>Trypanosoma brucei gambiense<\/italic> trypanosomiasis in Uganda.","volume":"93","author":"D Legros","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/649917","article-title":"How to shorten patient follow-up after treatment for <italic>Trypanosoma brucei gambiense<\/italic> sleeping sickness.","volume":"201","author":"D Mumba Ngoyi","year":"2010","journal-title":"J Infect Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0140-6736(09)61249-6","article-title":"Integration of control of neglected tropical diseases into health-care systems: challenges and opportunities.","volume":"375","author":"JO Gyapong","year":"2010","journal-title":"Lancet"},{"key":"ref29","year":"2009"},{"key":"ref30","year":"2009"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.3201\/eid1310.060358","article-title":"Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis.","volume":"13","author":"P Lutumba","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"ref32","first-page":"347","article-title":"[The efficiency of different detection strategies of human African trypanosomiasis by <italic>T. b.<\/italic> gambiense.]","volume":"10","author":"P Lutumba","year":"2005"},{"key":"ref33","year":"2010"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3201\/eid1602.090967","article-title":"Human African trypanosomiasis in areas without surveillance [letter].","volume":"16","author":"F Chappuis","year":"2010","journal-title":"Emerg Infect Dis"}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0000720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T17:23:46Z","timestamp":1539969826000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0000720"}},"subtitle":[],"editor":[{"given":"Marleen","family":"Boelaert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,5,25]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,5,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0000720","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,25]]}}}